Lower GPER1 expression in macrophages correlates with increased macrophage proliferation and tumor progression, while activation of GPER1 signaling suppresses macrophage proliferation via the MEK/ERK pathway and reduces PD-L1 expression, delaying tumor growth (45). Here, MAP2K7 is linked to neoplasm.